Financial statements Pharmapolis
Balance sheet data of PHARMAPOLIS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 808 005,82 | 6 276 461,78 | 8 468 912,89 | 12 515 085,17 | 15 931 706,56 | 19 585 387,94 |
| A. Fixed assets | 2 608 419,55 | 5 921 734,15 | 8 313 399,21 | 11 972 148,69 | 14 982 350,34 | 17 004 973,52 |
| B. Current assets | 199 586,27 | 354 727,63 | 155 513,68 | 542 936,48 | 949 356,22 | 2 580 414,42 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 808 005,82 | 6 276 461,78 | 8 468 912,89 | 12 515 085,17 | 15 931 706,56 | 19 585 387,94 |
| A. Equity | 2 281 330,98 | 4 268 698,86 | 5 226 887,88 | 5 177 843,47 | 6 702 135,75 | 16 130 694,66 |
| B. Liabilities and provisions for liabilities | 526 674,84 | 2 007 762,92 | 3 242 025,01 | 7 337 241,70 | 9 229 570,81 | 3 454 693,28 |
| I. Long-term liabilities | 402 000,00 | 656 919,03 | 2 689 984,70 | 6 959 661,60 | 8 520 023,59 | 2 754 272,67 |
| II. Short-term liabilities | 124 674,84 | 1 335 843,89 | 552 040,31 | 377 580,10 | 709 547,22 | 700 420,61 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.